Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus

Kaposiform hemangioendothelioma (KHE) is an extremely rare, locally aggressive vascular neoplasm. The etiopathogenesis of KHE is still poorly understood. In the present study, we found a new mutation in KHE (c.685delA, p.Thr229fs). The KHE patient with the PIK3CA mutation showed complete regression...

全面介紹

書目詳細資料

發表在:	Frontiers in Oncology
Main Authors:	Zuopeng Wang, Hanlei Yan, Yangyang Ma, Wei Yao, Shan Zheng, Kai Li
格式:	Article
語言:	英语
出版:	Frontiers Media S.A. 2023-05-01
主題:	PIK3CA mutation sirolimus Kaposiform hemangioendothelioma mTOR
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1132702/full